Passive smoking induces atherogenic changes in low-density lipoprotein

Circulation

Volumn 97, Issue 20, 1998, Pages 2012-2016

  Valkonen, Miia ^a   Kuusi, Timo ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Atherosclerosis; Coronary disease; Lipoproteins; Smoking

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; FREE RADICAL; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; RETINOL; THIOL DERIVATIVE; TOBACCO SMOKE; URATE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPOSURE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MACROPHAGE; MALE; NORMAL HUMAN; PASSIVE SMOKING; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032568476     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.20.2012     Document Type: Article

References (29)

1. Glantz SA, Parmley WW. Passive smoking and heart disease: mechanisms and risk. JAMA. 1995;273:1047-1053.
2. Gvozdjakova A, Kucharska J, Gvozdjak J. Effect of smoking on the oxidative processes of cardiomyocytes. Cardiology. 1992;81:81-84.
3. Brown RE, Nahser PJ, Rossen JD, Winniford MD. Passive exposure to environmental tobacco smoke causes coronary vasoconstriction in humans. Circulation. 1993;88(suppl I):I-260. Abstract.
4. Burghuber OC, Punzengruber C, Sinzinger H, Haber P, Silberbauer K. Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest. 1986;90:34-38.
5. Davis JW, Shelton L, Watanabe IS, Arnold J. Passive smoking affects endothelium and platelets. Arch Intern Med. 1989;149:386-389.
6. Tribble DL, Giuliano LJ, Fortmann SP. Reduced plasma ascorbic acid concentrations in nonsmokers regularly exposed to environmental tobacco smoke. Am J Clin Nutr. 1993;58:886-890.
7. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield JE. Passive smoking and impaired endothelium- dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334:150-154.
8. Diez Roux AV, Nieto FJ, Comstock GW, Howard G, Szklo M. The relationship of active and passive smoking to carotid atherosclerosis 12-14 years later. Prev Med. 1995;24:48-55.
9. Penn A, Chen LC, Snyder CA. Inhalation of steady-state side-stream smoke from one cigarette promotes arteriosclerotic plaque development. Circulation. 1994;90:1363-1367.
10. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect. 1985;64:111-126.
11. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223-261.
12. Schectman G, Byrd JC, Hoffman R. Ascorbic acid requirements for smokers: analysis of a population survey. Am J Clin Nutr. 1991;53:1466-1470.
13. Scheffler E, Wiest E, Woehrle J, Otto I, Schulz I, Huber L, Ziegler R, Dresel HA. Smoking influences the atherogenic potential of low-density lipoprotein. Clin Invest. 1992;70:263-268.
14. Frei B, Forte TM, Ames BN, Cross CE. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma: protective effects of ascorbic acid. Biochem J. 1991;277:133-138.
15. Chen C, Loo G. Cigarette smoke extract inhibits oxidative modification of low density lipoprotein. Atherosclerosis. 1995;112:177-185.
16. Valkonen M, Kuusi T. Spectrophotometric assay for total peroxyl radical- trapping potential in human serum. J Lipid Res. 1997;38:823-833.
17. Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. Biochem J. 1972;123:805-814.
18. Ulmer AJ, Flad HD. Discontinuous density gradient separation of human mononuclear leucocytes using Percoll as gradient medium. J Immunol Methods. 1979;30:1-10.
19. Recalde HR. A simple method of obtaining monocytes in suspension. J Immunol Methods. 1984;69:71-77.
20. Basu SK, Andersen RG, Goldstein JL, Brown MS. Metabolism of cationized lipoproteins by human fibroblasts: biochemical and morphologic correlations. J Cell Biol. 1977;74:119-135.
21. Regnstrom J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation, and coronary atherosclerosis in man. Lancet. 1992;339:1183-1186.
22. Niki E, Noguchi N, Tsuchihashi H, Gotoh N. Interaction among vitamin C, vitamin E, and beta-carotene. Am J Clin Nutr. 1995;62:1322S-1326S.
23. Maiorino M, Zamburlini A, Roveri A, Ursini F. Prooxidant role of vitamin E in copper induced lipid peroxidation. FEBS Lett. 1993;330:174-176.
24. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr. 1991;54: 1113S-1118S.
25. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
26. Roberts KA, Rezai AA, Pinkerton KE, Rutledge JC. Effect of environmental tobacco smoke on LDL accumulation in the artery wall. Circulation. 1996;94:2248-2253.
27. Rajs J, Rastenalmqvist P, Falck G, Eksborg S, Andersson BS. Sudden infant death syndrome: postmortem findings of nicotine and cotinine in pericardial fluid of infants in relation to morphological changes and position at death. Pediatr Pathol Lab Med. 1997;17:83-97.
28. Witschi H, Joad JP, Pinkerton KE. The toxicology of environmental tobacco smoke. Annu Rev Pharmacol Toxicol. 1997;37:29-52.
29. Kawachi I, Colditz GA, Speitzer FE, Manson JE, Stampfer MJ, Willett WC, Hennekens CH. A prospective study of passive smoking and coronary heart disease. Circulation. 1997;95:2374-2379.